| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |